NLR vs. ^NBI
NLR (VanEck Uranium and Nuclear ETF) is Uranium fund tracking the MVIS Global Uranium & Nuclear Energy Index, while ^NBI (NASDAQ Biotechnology Index) is an index. Over the past 10 years, NLR returned 12.50%/yr vs 9.64%/yr for ^NBI. At a 0.40 correlation, their price movements are largely independent.
Performance
NLR vs. ^NBI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NLR achieves a -5.48% return, which is significantly lower than ^NBI's 11.04% return. Over the past 10 years, NLR has outperformed ^NBI with an annualized return of 12.50%, while ^NBI has yielded a comparatively lower 9.64% annualized return.
NLR
- 1D
- -1.72%
- 1M
- -12.79%
- YTD
- -5.48%
- 6M
- -8.75%
- 1Y
- 10.82%
- 3Y*
- 29.67%
- 5Y*
- 19.89%
- 10Y*
- 12.50%
^NBI
- 1D
- 0.92%
- 1M
- 7.17%
- YTD
- 11.04%
- 6M
- 8.45%
- 1Y
- 49.73%
- 3Y*
- 15.72%
- 5Y*
- 4.35%
- 10Y*
- 9.64%
NLR vs. ^NBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NLR VanEck Uranium and Nuclear ETF | -5.48% | 56.50% | 14.26% | 36.67% | 2.29% | 13.63% | 3.49% | 0.20% | 4.94% | 8.25% |
^NBI NASDAQ Biotechnology Index | 11.04% | 32.40% | -1.37% | 3.74% | -10.91% | -0.63% | 25.69% | 24.41% | -9.32% | 21.06% |
Correlation
The correlation between NLR and ^NBI is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.38 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.34 |
Correlation (All Time) Calculated using the full available price history since Aug 15, 2007 | 0.40 |
The correlation between NLR and ^NBI shifts across timeframes, from 0.29 (1 year) to 0.40 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NLR vs. ^NBI — Risk / Return Rank
NLR
^NBI
NLR vs. ^NBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Uranium and Nuclear ETF (NLR) and NASDAQ Biotechnology Index (^NBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NLR | ^NBI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.22 | ||
| Sortino ratioReturn per unit of downside risk | -2.71 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 1.40 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | 0.37 | 5.91 | -5.55 |
| Martin ratioReturn relative to average drawdown | 0.77 | 18.83 | -18.06 |
Loading charts...
Drawdowns
NLR vs. ^NBI - Drawdown Comparison
The maximum NLR drawdown since its inception was -65.05%, smaller than the maximum ^NBI drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for NLR and ^NBI.
Loading charts...
Drawdown Indicators
| NLR | ^NBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.05% | -74.70% | +9.65% |
Max Drawdown (1Y)Largest decline over 1 year | -29.72% | -8.45% | -21.27% |
Max Drawdown (3Y)Largest decline over 3 years | -30.48% | -24.08% | -6.40% |
Max Drawdown (5Y)Largest decline over 5 years | -30.48% | -38.50% | +8.02% |
Max Drawdown (10Y)Largest decline over 10 years | -34.35% | -38.50% | +4.15% |
Current DrawdownCurrent decline from peak | -28.58% | 0.00% | -28.58% |
Average DrawdownAverage peak-to-trough decline | -35.68% | -26.54% | -9.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.05% | 2.65% | +11.40% |
Volatility
NLR vs. ^NBI - Volatility Comparison
VanEck Uranium and Nuclear ETF (NLR) has a higher volatility of 13.33% compared to NASDAQ Biotechnology Index (^NBI) at 7.01%. This indicates that NLR's price experiences larger fluctuations and is considered to be riskier than ^NBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NLR | ^NBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.33% | 7.01% | +6.32% |
Volatility (6M)Calculated over the trailing 6-month period | 32.82% | 15.72% | +17.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.83% | 20.22% | +22.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.66% | 22.01% | +7.65% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.27% | 23.34% | +0.93% |
Frequently Asked Questions
NLR and ^NBI have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NLR has higher volatility (13.33%) compared to ^NBI (7.01%). In terms of maximum drawdown, NLR dropped -65.05% vs ^NBI's -74.70%.
^NBI currently has the higher Sharpe Ratio (2.47 vs 0.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NLR and ^NBI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer